Table 3.
Characteristics of reports associated with eteplirsen.
| Factors | Eteplirsen |
|---|---|
| Number of reports | (N = 1480) |
| Gender | |
| Female | 29 (2.0 %) |
| Male | 1408 (95.1 %) |
| Missing | 43 (2.9 %) |
| Age (years) | |
| <18 | 774 (52.3 %) |
| 18–64.9 | 406 (27.4 %) |
| Missing | 300 (20.3 %) |
| Serious Outcome | |
| Hospitalization | 209 (13.2 %) |
| Death | 43 (2.7 %) |
| Life-threatening | 10 (0.6 %) |
| Disability | 2 (0.1 %) |
| Reporters | |
| Health Professional | 778 (52.6 %) |
| Consumer | 328 (22.2 %) |
| Pharmacists | 125 (8.4 %) |
| Medical doctor | 88 (5.9 %) |
| Other | 161 (10.9 %) |
| Reported Countries | |
| United States | 1469 (99.3 %) |
| Israel | 8 (0.5 %) |
| Canada | 1 (0.1 %) |
| United Kingdom | 1 (0.1 %) |
| India | 1 (0.1 %) |
| Report year | |
| 2016 | 1 |
| 2017 | 22 |
| 2018 | 229 |
| 2019 | 138 |
| 2020 | 187 |
| 2021 | 261 |
| 2022 | 239 |
| 2023 | 403 |